Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1

The synthesis and SAR of 4-(dimethylamino)quinazolines as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists are reported, leading to the discovery of ATC0175. The optimization of a series of 4-(dimethylamino)quinazoline antagonists of the melanin-concentrating hormone receptor 1 (MCH-R1)...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 15; no. 17; pp. 3853 - 3856
Main Authors: Kanuma, Kosuke, Omodera, Katsunori, Nishiguchi, Mariko, Funakoshi, Takeo, Chaki, Shigeyuki, Semple, Graeme, Tran, Thuy-Anh, Kramer, Bryan, Hsu, Debbie, Casper, Martin, Thomsen, Bill, Sekiguchi, Yoshinori
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 01-09-2005
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The synthesis and SAR of 4-(dimethylamino)quinazolines as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists are reported, leading to the discovery of ATC0175. The optimization of a series of 4-(dimethylamino)quinazoline antagonists of the melanin-concentrating hormone receptor 1 (MCH-R1) is described. The combination of the elaboration of both the linker portion and the terminal phenyl ring provided N-( cis-4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride 28 (ATC0175), which showed excellent antagonist activity at the MCH-R1 (IC 50 = 3.4 nM) as well as good selectivity over the Y5 and the α 2A receptors.
AbstractList The synthesis and SAR of 4-(dimethylamino)quinazolines as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists are reported, leading to the discovery of ATC0175. The optimization of a series of 4-(dimethylamino)quinazoline antagonists of the melanin-concentrating hormone receptor 1 (MCH-R1) is described. The combination of the elaboration of both the linker portion and the terminal phenyl ring provided N-( cis-4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride 28 (ATC0175), which showed excellent antagonist activity at the MCH-R1 (IC 50 = 3.4 nM) as well as good selectivity over the Y5 and the α 2A receptors.
The optimization of a series of 4-(dimethylamino)quinazoline antagonists of the melanin-concentrating hormone receptor 1 (MCH-R1) is described. The combination of the elaboration of both the linker portion and the terminal phenyl ring provided N-(cis-4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride 28 (ATC0175), which showed excellent antagonist activity at the MCH-R1 (IC50 = 3.4 nM) as well as good selectivity over the Y5 and the alpha2A receptors.
Author Funakoshi, Takeo
Kanuma, Kosuke
Hsu, Debbie
Chaki, Shigeyuki
Tran, Thuy-Anh
Kramer, Bryan
Thomsen, Bill
Omodera, Katsunori
Semple, Graeme
Sekiguchi, Yoshinori
Casper, Martin
Nishiguchi, Mariko
Author_xml – sequence: 1
  givenname: Kosuke
  surname: Kanuma
  fullname: Kanuma, Kosuke
  organization: Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan
– sequence: 2
  givenname: Katsunori
  surname: Omodera
  fullname: Omodera, Katsunori
  organization: Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan
– sequence: 3
  givenname: Mariko
  surname: Nishiguchi
  fullname: Nishiguchi, Mariko
  organization: Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan
– sequence: 4
  givenname: Takeo
  surname: Funakoshi
  fullname: Funakoshi, Takeo
  organization: Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan
– sequence: 5
  givenname: Shigeyuki
  surname: Chaki
  fullname: Chaki, Shigeyuki
  organization: Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan
– sequence: 6
  givenname: Graeme
  surname: Semple
  fullname: Semple, Graeme
  organization: Arena Pharmaceuticals Inc., 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
– sequence: 7
  givenname: Thuy-Anh
  surname: Tran
  fullname: Tran, Thuy-Anh
  organization: Arena Pharmaceuticals Inc., 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
– sequence: 8
  givenname: Bryan
  surname: Kramer
  fullname: Kramer, Bryan
  organization: Arena Pharmaceuticals Inc., 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
– sequence: 9
  givenname: Debbie
  surname: Hsu
  fullname: Hsu, Debbie
  organization: Arena Pharmaceuticals Inc., 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
– sequence: 10
  givenname: Martin
  surname: Casper
  fullname: Casper, Martin
  organization: Arena Pharmaceuticals Inc., 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
– sequence: 11
  givenname: Bill
  surname: Thomsen
  fullname: Thomsen, Bill
  organization: Arena Pharmaceuticals Inc., 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
– sequence: 12
  givenname: Yoshinori
  surname: Sekiguchi
  fullname: Sekiguchi, Yoshinori
  email: yoshi.sekiguchi@po.rd.taisho.co.jp
  organization: Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16984214$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16002290$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1rGzEQhkVISZyPP9BD0aXQQNcZrWTZC7mUkH6AoZcEchNa7WwssyttJSWQ3Pu_O8aG9lSQkDQ8r6R5zthxiAEZey9gLkDo6-28Hd0wrwEWcxqiFkdsJpRWlVSwOGYzaDRUq0Y9nrKznLcAQoFSJ-xUaIC6bmDGfq_RdjxOxY_-zRYfA489V9Wnzo9YNq-DHX2IV7-efbBvcfAB82c-xYKhcBs6nnFAV_wL0qnYpxh8Lpn3MfGyQT7iYIMPlYvBUSLRA-GJb2IaqROe0OFUCBUX7F1vh4yXh_WcPXy9u7_9Xq1_fvtx-2VdOblSpVrIpW6tpn2rZW-XUgJSI7KhSgNWCNROOyr3UC8agUq2y6amKR3aJfHnrN7f61LMOWFvpuRHm16NALNzarZm59TsnBoa5JRCH_ah6bkdsfsbOUgk4OMBsNnZoU82OJ__4ZqVqoUi7mbPIbX44jGZ7DySmc6TimK66P_3jz85X5iy
CitedBy_id crossref_primary_10_1016_j_tet_2006_01_010
crossref_primary_10_1016_j_bmcl_2012_03_049
crossref_primary_10_1016_j_drudis_2007_08_010
crossref_primary_10_1016_j_lfs_2007_05_029
crossref_primary_10_1016_j_bmcl_2006_06_056
crossref_primary_10_1016_j_bmcl_2006_04_061
crossref_primary_10_1016_j_bmcl_2009_09_003
crossref_primary_10_1186_1752_153X_7_95
crossref_primary_10_1016_j_bmcl_2006_04_062
crossref_primary_10_1016_j_bmcl_2006_10_053
crossref_primary_10_1016_j_bmcl_2006_10_052
crossref_primary_10_1016_j_bmcl_2006_10_096
crossref_primary_10_1016_j_bmc_2005_12_052
crossref_primary_10_1002_ddr_20029
crossref_primary_10_1016_j_bmcl_2006_10_056
crossref_primary_10_1016_j_bmcl_2006_06_049
crossref_primary_10_1021_cr050984g
crossref_primary_10_1002_ejoc_201000460
crossref_primary_10_1016_j_bmcl_2006_06_045
crossref_primary_10_1021_jm5000408
crossref_primary_10_1021_jm500039e
crossref_primary_10_1002_chin_200551214
crossref_primary_10_1517_17460441_2_10_1301
crossref_primary_10_1016_j_bmcl_2006_07_040
crossref_primary_10_1016_j_tet_2007_07_073
Cites_doi 10.1124/jpet.104.081711
10.1016/S0014-5793(96)01160-X
10.1038/380243a0
10.1016/S0031-9384(99)00117-1
10.1210/endo-125-3-1660
10.1210/en.138.1.351
10.1038/25341
10.1038/nm0902-1039b
10.1016/j.bmcl.2005.03.052
10.1016/0196-9781(95)02092-6
10.1016/S0014-2999(02)01314-6
ContentType Journal Article
Copyright 2005 Elsevier Ltd
2005 INIST-CNRS
Copyright_xml – notice: 2005 Elsevier Ltd
– notice: 2005 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/j.bmcl.2005.05.121
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3405
EndPage 3856
ExternalDocumentID 10_1016_j_bmcl_2005_05_121
16002290
16984214
S0960894X05007134
Genre Journal Article
GroupedDBID ---
--K
--M
.HR
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6TJ
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABTAH
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D0L
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCB
SCC
SDF
SDG
SDP
SES
SEW
SOC
SPC
SPCBC
SPT
SSH
SSK
SSP
SSU
SSZ
T5K
WUQ
XFK
XPP
Y6R
YK3
ZMT
ZY4
~02
~G-
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
ID FETCH-LOGICAL-c384t-5376ba6384b63fa7330e0023938490a11e6c6c733f02591e43b792b793cea7a73
ISSN 0960-894X
IngestDate Thu Sep 26 16:09:18 EDT 2024
Sat Sep 28 07:44:39 EDT 2024
Sun Oct 22 16:05:46 EDT 2023
Fri Feb 23 02:23:02 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 17
Keywords Melanin-concentrating hormone receptor 1 antagonists
MCH-R1 antagonists
ATC0175
Cyclohexane derivatives
Spacer arm
Quinazoline derivatives
Selectivity
Optimization
Structure activity relation
Hydrochlorides
Organic fluorine compounds
Melanin concentrating hormone
Benzamide derivatives
Carboxamide
Antagonist
Chemical synthesis
Biological receptor
Hormonal receptor
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c384t-5376ba6384b63fa7330e0023938490a11e6c6c733f02591e43b792b793cea7a73
PMID 16002290
PageCount 4
ParticipantIDs crossref_primary_10_1016_j_bmcl_2005_05_121
pubmed_primary_16002290
pascalfrancis_primary_16984214
elsevier_sciencedirect_doi_10_1016_j_bmcl_2005_05_121
PublicationCentury 2000
PublicationDate 2005-09-01
PublicationDateYYYYMMDD 2005-09-01
PublicationDate_xml – month: 09
  year: 2005
  text: 2005-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Bioorganic & medicinal chemistry letters
PublicationTitleAlternate Bioorg Med Chem Lett
PublicationYear 2005
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Takekawa, Asami, Ishihara, Terauchi, Kato, Shimomura, Mori, Murakoshi, Kato, Suzuki, Nishimura, Fujino (bib6) 2002; 438
Sekiguchi, Y.; Kanuma, K.; Omodera, K.; Tran, T. A.; Kramer, B. A.; Beeley N. R. A. International Patent WO 28641, 2003.
Qu, Ludwig, Grammeltoft, Piper, Pelleymounter, Cullen, Mathes, Przypek, Kanarek, Maratos-Flier (bib3) 1996; 380
Rossi, Choi, O’Shea, Miyoshi, Ghatei, Bloom (bib4) 1997; 138
Monzon, De Barioglio (bib8) 1999; 67
Gonzalez, Vaziri, Wilson (bib7) 1996; 17
Borowsky, Durkin, Ogozalek, Marzabadi, Deleon, Heurich, Lichtblau, Shaposhnik, Daniewska, Blackburn, Branchek, Gerald, Vaysse, Forray (bib9) 2002; 8
Chaki, Funakoshi, Hirota-Okuno, Nishiguchi, Shimazaki, Iijima, Grottick, Kanuma, Omodera, Sekiguchi, Okuyama, Tran, Semple, Thomsen (bib12) 2005; 313
Kanuma, Omodera, Nishiguchi, Funakoshi, Chaki, Semple, Tran, Kramer, Hsu, Casper, Thomsen, Beeley, Sekiguchi (bib10) 2005; 15
Kolakowski, Jung, Nguyen, Johnson, Lynch, Cheng, Heng, George, O’Dowd (bib2) 1996; 398
Shimada, Tritos, Lowell, Flier, Maratos-Flier (bib5) 1998; 396
Vaughan, Fischer, Hoeger, Rivier, Vale (bib1) 1989; 125
Gonzalez (10.1016/j.bmcl.2005.05.121_bib7) 1996; 17
Vaughan (10.1016/j.bmcl.2005.05.121_bib1) 1989; 125
Borowsky (10.1016/j.bmcl.2005.05.121_bib9) 2002; 8
Kanuma (10.1016/j.bmcl.2005.05.121_bib10) 2005; 15
Shimada (10.1016/j.bmcl.2005.05.121_bib5) 1998; 396
10.1016/j.bmcl.2005.05.121_bib11
Takekawa (10.1016/j.bmcl.2005.05.121_bib6) 2002; 438
Chaki (10.1016/j.bmcl.2005.05.121_bib12) 2005; 313
Monzon (10.1016/j.bmcl.2005.05.121_bib8) 1999; 67
Kolakowski (10.1016/j.bmcl.2005.05.121_bib2) 1996; 398
Qu (10.1016/j.bmcl.2005.05.121_bib3) 1996; 380
Rossi (10.1016/j.bmcl.2005.05.121_bib4) 1997; 138
References_xml – volume: 438
  start-page: 129
  year: 2002
  ident: bib6
  publication-title: Eur. J. Pharmacol.
  contributor:
    fullname: Fujino
– volume: 138
  start-page: 351
  year: 1997
  ident: bib4
  publication-title: Endocrinology
  contributor:
    fullname: Bloom
– volume: 313
  start-page: 831
  year: 2005
  ident: bib12
  publication-title: J. Pharmacol. Exp. Ther.
  contributor:
    fullname: Thomsen
– volume: 125
  start-page: 1660
  year: 1989
  ident: bib1
  publication-title: Endocrinology
  contributor:
    fullname: Vale
– volume: 17
  start-page: 171
  year: 1996
  ident: bib7
  publication-title: Peptides
  contributor:
    fullname: Wilson
– volume: 67
  start-page: 813
  year: 1999
  ident: bib8
  publication-title: Physiol. Behav.
  contributor:
    fullname: De Barioglio
– volume: 15
  start-page: 2565
  year: 2005
  ident: bib10
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Sekiguchi
– volume: 380
  start-page: 243
  year: 1996
  ident: bib3
  publication-title: Nature
  contributor:
    fullname: Maratos-Flier
– volume: 396
  start-page: 670
  year: 1998
  ident: bib5
  publication-title: Nature
  contributor:
    fullname: Maratos-Flier
– volume: 8
  start-page: 825
  year: 2002
  ident: bib9
  publication-title: Nat. Med.
  contributor:
    fullname: Forray
– volume: 398
  start-page: 253
  year: 1996
  ident: bib2
  publication-title: FEBS Lett.
  contributor:
    fullname: O’Dowd
– volume: 313
  start-page: 831
  year: 2005
  ident: 10.1016/j.bmcl.2005.05.121_bib12
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.104.081711
  contributor:
    fullname: Chaki
– volume: 398
  start-page: 253
  year: 1996
  ident: 10.1016/j.bmcl.2005.05.121_bib2
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(96)01160-X
  contributor:
    fullname: Kolakowski
– volume: 380
  start-page: 243
  year: 1996
  ident: 10.1016/j.bmcl.2005.05.121_bib3
  publication-title: Nature
  doi: 10.1038/380243a0
  contributor:
    fullname: Qu
– volume: 67
  start-page: 813
  year: 1999
  ident: 10.1016/j.bmcl.2005.05.121_bib8
  publication-title: Physiol. Behav.
  doi: 10.1016/S0031-9384(99)00117-1
  contributor:
    fullname: Monzon
– volume: 125
  start-page: 1660
  year: 1989
  ident: 10.1016/j.bmcl.2005.05.121_bib1
  publication-title: Endocrinology
  doi: 10.1210/endo-125-3-1660
  contributor:
    fullname: Vaughan
– volume: 138
  start-page: 351
  year: 1997
  ident: 10.1016/j.bmcl.2005.05.121_bib4
  publication-title: Endocrinology
  doi: 10.1210/en.138.1.351
  contributor:
    fullname: Rossi
– volume: 396
  start-page: 670
  year: 1998
  ident: 10.1016/j.bmcl.2005.05.121_bib5
  publication-title: Nature
  doi: 10.1038/25341
  contributor:
    fullname: Shimada
– volume: 8
  start-page: 825
  year: 2002
  ident: 10.1016/j.bmcl.2005.05.121_bib9
  publication-title: Nat. Med.
  doi: 10.1038/nm0902-1039b
  contributor:
    fullname: Borowsky
– volume: 15
  start-page: 2565
  year: 2005
  ident: 10.1016/j.bmcl.2005.05.121_bib10
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2005.03.052
  contributor:
    fullname: Kanuma
– volume: 17
  start-page: 171
  year: 1996
  ident: 10.1016/j.bmcl.2005.05.121_bib7
  publication-title: Peptides
  doi: 10.1016/0196-9781(95)02092-6
  contributor:
    fullname: Gonzalez
– volume: 438
  start-page: 129
  year: 2002
  ident: 10.1016/j.bmcl.2005.05.121_bib6
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/S0014-2999(02)01314-6
  contributor:
    fullname: Takekawa
– ident: 10.1016/j.bmcl.2005.05.121_bib11
SSID ssj0014044
Score 1.9931775
Snippet The synthesis and SAR of 4-(dimethylamino)quinazolines as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists are reported, leading to the discovery...
The optimization of a series of 4-(dimethylamino)quinazoline antagonists of the melanin-concentrating hormone receptor 1 (MCH-R1) is described. The combination...
SourceID crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 3853
SubjectTerms ATC0175
Biological and medical sciences
Hormones. Endocrine system
Humans
Inhibitory Concentration 50
MCH-R1 antagonists
Medical sciences
Melanin-concentrating hormone receptor 1 antagonists
Pharmacology. Drug treatments
Quinazolines - chemical synthesis
Quinazolines - chemistry
Quinazolines - pharmacology
Radioligand Assay
Receptors, Somatostatin - antagonists & inhibitors
Structure-Activity Relationship
Substrate Specificity
Title Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1
URI https://dx.doi.org/10.1016/j.bmcl.2005.05.121
https://www.ncbi.nlm.nih.gov/pubmed/16002290
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6TgIkhKDjMi6THxAClUy5OGnyWI2igQQ8rEh7i5zU6bK2dmmah_HO_-ac2Ll0GgiQkNqkddI67flyfOxz-Qh56TKwgQMns1IvGVksslMrcd3E4mE28xw-yxyB-c6nZ6PP5-G7CZv0enW-dtv2XyUNbSBrzJz9C2k3XwoN8BpkDluQOmz_SO7ImTlUoAhWJsMSzUFmgSE5y5Eu-gogkCPfdvStzCX_jqQ9WlWs1bYOOC8qdhwMKoI_ns8VltctmojElVhymUsrxZRHWdXdlfPhBVi_SiILC0bKwKnOjsM4V5pAKq3AZlz6WJykZpwbLqvMota5xGW50glrqigXDQC_IHnPxmSybYtSqk3e8a5c5HPkdzF5SPlCNQgtJV-oQh-a8oVQOysefhPSZZbh6lScNu6pWs8MbCuMdLjnsdDanAXM8pjt76h7vwvrUUd5e6GuW2wMAXgb3DjI6PWOy-NklS7NqpyPVTraIbUJdDzDy8Krsn2dtrtH9l1QiaxP9scfJucfG48Xsyvi4eZnmAQvHYt4vadfGVF317yAWzvTnCzXZkqVxTS9T-6ZqQ4da4w-ID0hB-RgLPlWra7oK1oFH1denQG5fVLDYEBufTLxHgfkB6KZdtFMVUaZ9XoHy2-6SH5LNY4p4Jg2OKYdHFPAMQUc0xtxTA2OaY1j6jwkX99PpienliEOAY0Tsq2FJYoSDiMLSwIv4yPPs4Uu9heCNuKOI4I0SKE5A4s_cgQDPRW58PRSwUdw_iPSl9DTE0LZLIA5TerZTAjYuzzygyTJshDsbp5ydkiGtSTita4PE9eBk5cxyg2JXv0YHiC3Q-LXwoqNhast1xiw9dvPHe1Itu0qiELmOnAZj7WoO0fQPI_sp__Y5TNyp733npP-dlOKF2SvmJVHBro_Ab7S4Zk
link.rule.ids 315,782,786,27934,27935
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lead+optimization+of+4-%28dimethylamino%29quinazolines%2C+potent+and+selective+antagonists+for+the+melanin-concentrating+hormone+receptor+1&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Kanuma%2C+Kosuke&rft.au=Omodera%2C+Katsunori&rft.au=Nishiguchi%2C+Mariko&rft.au=Funakoshi%2C+Takeo&rft.date=2005-09-01&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=15&rft.issue=17&rft.spage=3853&rft.epage=3856&rft_id=info:doi/10.1016%2Fj.bmcl.2005.05.121&rft.externalDocID=S0960894X05007134
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon